EdiGene
PrivateLast Round
Series B
Extension
Apr 21, 2021
Total Funding Raised
$160M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EdiGene is a biotechnology company that develops genome editing technologies to accelerate drug discovery and create novel therapeutics for genetic diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EdiGene Comparables
Compare EdiGene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BRL Medicine Inc. | 87% | |
| Shanghai Bendao Gene Technology | 84% | |
| AIRNA | 80% | |
EdiGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 21, 2021 | ||||
| Series B | Oct 13, 2020 | ||||
| Series A Extension | Sep 16, 2019 | ||||
| Series A Extension | Feb 4, 2019 | ||||
| VC Round | Aug 24, 2018 |
EdiGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series B Extension, Series B |
| BioTrack Capital | Series B Extension |
| BGI Co-Win | VC Round |
| Loyal Valley Capital | Series B Extension |
| IDG Capital | VC Round, Series B Extension, Series B, Series A Extension, Series A |
| Sincere Capital | VC Round, Series B |
| WI Harper Group | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 144% MoM.
- Apr 15, 2026
Monthly visitors grew 120% MoM.
EdiGene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EdiGene's valuation, stock price, and market status.